866138-91-2

Upstream product

• 86771-48-4 (4R)-4-[(4-methoxybenzyl)oxymethyl]-γ-butyrolactone 
• 52813-63-5 (5R)-2,3,4,5-tetrahydro-5-hydroxymethyl-2-furanone 
• 866138-77-4 (R)-4-benzyl-3-((R)-4-(tert-butyldimethylsilyloxy)-5-(4-methoxybenzyloxy)pentanoyl)oxazolidin-2-one 
• 866138-76-3 (R)-4-(tert-butyldimethylsilyloxy)-5-(4-methoxybenzyloxy)pentanoic acid 
• 866138-90-1 (R)-4-benzyl-3-((R)-4-(tert-butyldimethylsilyloxy)-5-hydroxypentanoyl)oxazolidin-2-one 

Downstream Products

• 866138-78-5 ethyl (2E,4R)-7-((R)-4-benzyl-2-oxo-1,3-oxazolidin-3-yl)-4-(tert-butyldimethylsilyloxy)-7-oxohept-2-enoate 
• 866138-96-7 ethyl (2E,4R,6S,7S,10S,12E)-4-(tert-butyldimethylsilyloxy)-10-(tert-butyldiphenylsilyloxy)-7-(methanesulfonyloxy)-6-(trityloxymethyl)tetradeca-2,12-dienoate 
• 866138-88-7 ethyl (2E,4R,6S,7S,10S,12E)-4-(tert-butyldimethylsilyloxy)-10-(tert-butyldiphenylsilyloxy)-7-hydroxy-6-(trityloxymethyl)tetradeca-2,12-dienoate 
• 866138-87-6 ethyl (2E,4R,6R,7S,10S,12E)-6-((R)-4-benzyl-2-oxo-1,3-oxazolidine-3-carbonyl)-4-(tert-butyldimethylsilyloxy)-10-(tert-butyldiphenylsilyloxy)-7-hydroxytetradeca-2,12-dienoate 
• 866138-98-9 (2E,12E)-(4R,6R,7S,10S)-4-(tert-Butyl-dimethyl-silanyloxy)-10-(tert-butyl-diphenyl-silanyloxy)-7-methanesulfonyloxy-6-(pyridin-2-ylselanylmethyl)-tetradeca-2,12-dienoic acid ethyl ester 
• 866138-97-8 ethyl (2E,4R,6S,7S,10S,12E)-4-(tert-butyldimethylsilyloxy)-10-(tert-butyldiphenylsilyloxy)-7-hydroxy-6-((2-pyridylselenyl)methyl)tetradeca-2,12-dienoate 
• 866138-95-6 ethyl (2E,4R,6S,7S,10S,12E)-4-(tert-butyldimethylsilyloxy)-10-(tert-butyldiphenylsilyloxy)-7-hydroxy-6-(hydroxymethyl)tetradeca-2,12-dienoate 

Relevant academic research and scientific papers

Synthesis of (-)-amphidinolide K fragment C9-C22

(Chemical Equation Presented) The key fragment (2a or 2b) in a total synthesis of the cytotoxic macrolide (-)-amphidinolide K (1) has been achieved from synthons C9-C14 (3) and C15-C22 (4), which have both been prepared from glutamic acid in good overall yields.